Agribody Technologies will employ Benson Hill Biosystem’s novel gene editing system to express gene targets validated to increase yield, stress tolerance and shelf life
ST. LOUIS—August 22, 2018—Benson Hill Biosystems, a crop improvement company unlocking the natural genetic diversity of plants, and Agribody Technologies, Inc., an emerging agricultural biotechnology company, are partnering to deliver non-GMO yield and sustainability traits for seed companies working in corn, soy, alfalfa, cotton, sugarbeets, canola, potatoes, peanut, beans, rice, sorghum, wheat, and flowers.
Agribody Technologies has identified and validated a portfolio of highly conserved genes with broad application in multiple crops, including the regulation of two genes (elF-5A and DHS) that significantly improve plant productivity and sustainability. These stable genetic components deliver increased biomass and seed yields, delayed spoilage for increased shelf life and enhanced tolerance to diseases and abiotic stresses such as drought, heat, cold, salt, low nutrients, or crowding. Agribody Technologies will employ Benson Hill’s novel gene editing system to unlock these genetic components and provide co-development opportunities for companies working in multiple row and specialty crops.
“We have gained deep understanding and validation of these genes through multiple years of laboratory, greenhouse and field trials,” said Jerry Feitelson, CEO and co-founder of Agribody Technologies. “We have been very impressed with Benson Hill’s commitment to democratizing genome editing methods and their excellent reputation with seed companies. Our collaboration enables companies working on both large and smaller-acre crops to leverage these genes already present in the crop for both farmer and consumer benefit.”
Benson Hill empowers organizations of any size to access the most advanced tools in seed innovation, accelerating their R&D programs without major infrastructure costs or distraction from their core business. The Edit system combines the analytical power of Benson Hill’s CropOS™ computational platform with a robust portfolio of novel genome editing nucleases. Partners can leverage the natural genetic diversity of plants and optimize flavor profiles, nutrient-density, and environmental sustainability with greater speed and precision than previously possible,improving the cost and timeline of product development.
“Reducing food waste, improving resource-use efficiency and increasing resilience to climate change are some of the most urgent challenges in our food system,” said Matt Crisp, CEO and co-founder of Benson Hill Biosystems. “Agribody Technologies has demonstrated the power of harnessing the natural genetic diversity that exists within plants to address these needs, a goal that aligns squarely with our mission. We look forward to making these benefits readily accessible to crop innovators.”
About Agribody Technologies
ATI applies a proven contribution to food security that helps to deal with growing populations, extreme weather and decreasing farmland by significantly increasing crop yields and shelf life of perishable products. Our patent-protected genetic modification (GM) or genome editing (GE) technology targets a validated, very early biological switch the delays plant senescence, while increasing resistance to diseases and sublethal stresses such as drought, heat, cold, salt, low nutrients and crowding in many key crop plants, including 2 years of field trial data in an elite line of alfalfa. Several licenses and co-development projects with innovative seed companies are underway.
About Benson Hill Biosystems
Benson Hill empowers innovators with a revolutionary crop design platform to develop healthier and more sustainable crops. Our CropOS™ platform combines machine learning and big data with genome editing and plant biology to drastically accelerate and simplify the product development process. More information can be found online at www.bensonhillbio.com. Follow us on Twitter at @BensonHillBio.
Benson Hill Biosystems:
Agribody Technologies, Inc.:
Jerry Feitelson, Ph.D.